EDMONTON, Oct. 2 /CNW/ - Ceapro Inc. (TSX-V: CZO) today announced the appointment of Mr. Branko Jankovic as Controller, effective today. For the past nine years, Mr. Jankovic has been a business consultant providing consulting services to public, private, and government clients. He currently serves as a director of ProMetic Life Sciences Inc. (TSX: PLI). Mr. Jankovic graduated from Lakehead University in 1983 with a Bachelor's Degree in Commerce and was awarded Dean Braun medal for top standing. He articled with Collins Barrow in Edmonton and obtained the Chartered Accountant designation in 1985 from the Institute of Chartered Accountants in Alberta. With regret, we announce the resignation of Mr. Shawn McMillan as Chief Financial Officer, effective October 15, 2006. Mr. McMillan has accepted a senior position with a public security firm in Edmonton. The Board and Management of Ceapro thank him for his service and contribution to the Company and wish him well in his new position. Ceapro's President and CEO, Dr. Redmond, will serve as CFO on an interim basis until a new appointment is made. About Ceapro Inc. Ceapro Inc. is a growth stage biotechnology company. Ceapro's core technology is the extraction of functional, active ingredients. We will continue to add value to our extracts by manufacturing medical and therapeutic products, support the use of our extracts in products for human and animal health, and introduce health and wellness services employing our CeaProve(R) diagnostic technology. Ceapro shares trade on the TSX Venture Exchange under the symbol CZO. To learn more about Ceapro, visit our website at www.ceapro.com. Shares Outstanding: 37,098,670, Recent Close: $0.32. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or the accuracy of this news release. This release may contain forward-looking statements. Various factors could cause actual results to differ materially from those projected in forward-looking statements. Although the Company believes that the forward-looking statements contained herein are reasonable, it can give no assurance that the Company's expectations are correct. All forward-looking statements are expressly qualified in their entirety by this cautionary statement. %SEDAR: 00010110E
Ceapro Reports Management Changes
Earlier from Ceapro
- Ceapro announces 2006 second quarter financial results
- Ceapro named on Profit 100 list of Canada's fastest-growing companies
- Ceapro Inc. - Annual General Meeting Webcast - June 1, 2006
- Ceapro announces 2006 first quarter financial results
- Ceapro receives prestigious international award
Later from Ceapro
- Ceapro announces 2006 third quarter financial results
- /C O R R E C T I O N from source -- Ceapro Inc./
- Ceapro update on legal proceedings against the Government of Saskatchewan, Saskatchewan Government Growth Fund Management Corporation, Gary K. Benson, Janice McKinnon, and Can-Oat Milling Products Inc.
- Ceapro announces establishment of Ceapro BioEnergy Inc.
- Ceapro tackles diabetes head on
Follow Ceapro into a list and get an email when it puts out news.
Follow Ceapro